Fibroblast growth factor 8 expression in breast carcinoma: Associations with androgen receptor and prostate-specific antigen expressions

Virchows Archiv

Volumn 441, Issue 4, 2002, Pages 380-384

  Tanaka, Akira ^a   Kamiakito, Tomoko ^a   Takayashiki, Norio ^a   Sakurai, Shinji ^a   Saito, Ken ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Androgen receptor; Breast cancer; Fibroblast growth factor 8; Immunohistochemistry; Prostate specific antigen

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR 8; PROGESTERONE RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; FEMALE; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0036914027     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-002-0687-9     Document Type: Article

References (28)

1. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G (1996) Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 88:291-296
2. Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Kandioler-Eckers-berger D, Gnant M, Jakesz R (2001) Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. Clin Cancer Res 7:1669-1675
3. Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD (1995) Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 52:459-467
4. Daphna-Iken D, Shankar DB, Lawshé A, Ornitz DM, Shackle-ford GM, MacArthur CA (1998) MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Oncogene 17:2711-2717
5. Dickson C, Smith R, Brookes S, Peters G (1984) Tumorigenesis by mouse mammary tumor virus: Proviral activation of a cellular gene in the common integration region int-2. Cell 37:529-536
6. Dorkin TJ, Robinson MC, Marsh C, Bjartell A, Neal DE, Leung HY (1999) FGF8 over-expression in prostate cancer is associated with decreased patient survival and persists in androgen independent disease. Oncogene 18:2755-2761
7. Fioravanti L, Cappelletti V, Coradini D, Miodini P, Borsani G, Daidone MG, Di Fronzo G (1997) int-2 oncogene amplification and prognosis in node-negative breast carcinoma. Int J Cancer 74:620-624
8. Hall RE, Clements JA, Birrell SN, Tilley WD (1998) Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours. Br J Cancer 78:360-365
9. Heyl W, Wolff JM, Biesterfeld S, Schroder W, Zitzelsberger D, Jakse G, Rath W (1999) Immunohistochemical analysis of prostate-specific antigen does not correlate to other prognostic factors in breast cancer. Anticancer Res 19:2563-2565
10. Kitsberg DI, Leder P (1996) Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarci-noma in transgenic mice. Oncogene 13:2507-2515
11. Kuenen-Boumeester V, Van der Kwast TH, Claassen CC, Look MP, Liem GS, Klijn JGM, Henzen-Logmans SC (1996) The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters. Eur J Cancer 32A:1560-1565
12. Layfield LJ, Gupta D, Mooney EE (2000) Assessment of tissue estrogen and progesterone receptor levels: A survey of current practice, techniques, and quantitation methods. Breast J 6:189-196
13. Marsh SK, Bansal GS, Zammit C, Barnard R, Coope R, Roberts-Clarke D, Gomm JJ, Coombes RC, Johnston CL (1999) Increased expression of fibroblast growth factor 8 in human breast cancer. Oncogene 18:1053-1060
14. Miller MK, Unger PD, Bleiweiss IJ (2001) Immunohisto-chemical analysis of prostate specific antigen in breast cancer. Breast Cancer Res Treat 68:111-116
15. Muller WJ, Lee FS, Dickson C, Peters G, Pattengale P, Leder P (1990) The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J 9:907-913
16. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M (1996) Receptor specificity of the fibroblast growth factor family. J Biol Chem 271:15292-15297
17. Peters G, Brookes S, Smith R, Placzek M, Dickson C (1989) The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors. Proc Natl Acad Sci U S A 86:5678-5682
18. Ruohola JK, Viitanen TP, Valve EM, Seppánen JA, Loponen NT, Keskitalo JJ, Lakkakorpi PT, Hárkönen PL (2001) Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Cancer Res 61:4229-4237
19. Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H, Matsumoto K (1992) Cloning and characterization of an androgen-induced growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells. Proc Natl Acad Sci U S A 89:8928-8932
20. Tanaka A, Miyamoto K, Matsuo H, Matsumoto K, Yoshida H (1995) Human androgen-induced growth factor in prostate and breast cancer cells: Its molecular cloning and growth properties. FEBS Lett 363:226-230
21. Tanaka A, Furuya A, Yamasaki M, Hanai N, Kuriki K, Kamiakito T, Kobayashi Y, Yoshida H, Koike M, Fukayama M (1998) High frequency of fibroblast growth factor (FGF) 8 expression in clinical prostate cancers and breast tissues, immunohistochemically demonstrated by a newly established neutralizing monoclonal antibody against FGF 8. Cancer Res 58:2053-2056
22. Tanaka A, Kamiakito T, Hakamata Y, Fu jii A, Kuriki K, Fukayama M (2001) Extensive neuronal localization and neu-rotrophic function of fibroblast growth factor 8 in the nervous system. Brain Res 912:105-115
23. Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, Yamamoto H, Miyajima N, Toyoshima K, Yamamoto T, Yokota J, Yoshida T, Sakamoto H, Terada M, Sugimura T (1989) Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplifi-cation units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res 49:3104-3108
24. Tsuda H, Akiyama F, Kurosumi M, Sakamoto G, Watanabe T (1998) Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Jpn J Clin Oncol 28:486-491
25. Valve EM, Nevalainen MT, Nurmi MJ, Laato MK, Martikainen PM, Hárkönen PL (2001) Increased expression of FGF-8 isoforms and FGF receptors in human premalignant prostatic intraepithelial neoplasia lesions and prostate cancer. Lab Invest 81:815-826
26. Yan G, Fukabori Y, McBride G, Nikolaropolous S, McKeehan WL (1993) Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 13:4513-4522
27. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, Roagna R, Ponzone R, Sismondi P (1995) Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55:2104-2110
28. Zhou J, Ng S, Adesanya-Famuiya O, Anderson K, Bondy CA (2000) Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 14:1725-1730